Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 11, 2018SHILAP Revista de lepidopterologíaOpen Access

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

RWRebekka WeberUniversity of MannheimVFViktor FlemingQueen's University BelfastXHXiaoying HuFujian Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Weber et al. (2018) studied this question.

synapsesocial.com/papers/69d8efae183921ebcaae40behttps://doi.org/10.3389/fimmu.2018.01310
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics2008 · 344 citations
  2. 2Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer2009 · 470 citations
  3. 3Mechanism of All- <i>Trans</i> Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells2007 · 422 citations
  4. 4Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma2016 · 142 citations
  5. 5CCR5 Directs the Mobilization of CD11b+Gr1+Ly6Clow Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor Development2017 · 95 citations